CRISPR Therapeutics AG
2 clinical trials · 2 recruiting · INDUSTRY
Trials by CRISPR Therapeutics AG
RECRUITINGPhase 1 / Phase 2NCT05565248
An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects...
This is an open-label, multicenter, Phase 1/2 study evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects with T1D
Sponsor: CRISPR Therapeutics AGEnrolling: 402 locations
Diabetes MellitusDiabetes Mellitus, Type 1Glucose Metabolism Disorders+4
RECRUITINGPhase 1NCT07491172
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
This is a single-arm, open-label, multicenter, ascending dose Phase 1 trial that will enroll participants 18 to 75 years of age with dyslipidemias that are refractory to available...
Sponsor: CRISPR Therapeutics AGEnrolling: 9018 locations
CardiovascularMetabolic DiseaseDyslipidemias+7